Zai Lab (ZLAB) Enterprise Value Growth (1y) (2017 - 2026)
Zai Lab (ZLAB) Enterprise Value Growth (1y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Zai Lab | 21.37 Bn | 21.37 Bn | -34.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.05% |
| Dec 31, 2025 | 87.02% |
| Sep 30, 2025 | -14.11% |
| Jun 30, 2025 | -73,682.80% |
| Mar 31, 2025 | -0.06% |
| Dec 31, 2024 | -70,778.82% |
| Sep 30, 2024 | -2,091.14% |
| Jun 30, 2024 | 99.87% |
| Mar 31, 2024 | 89.13% |
| Dec 31, 2023 | 99.89% |
| Sep 30, 2023 | 97.08% |
| Jun 30, 2023 | 30.37% |
| Mar 31, 2023 | 29.10% |
| Dec 31, 2022 | 28.43% |
| Sep 30, 2022 | 28.63% |
| Jun 30, 2022 | 28.90% |
| Mar 31, 2022 | -29.49% |
| Dec 31, 2021 | -18.73% |
| Sep 30, 2021 | -791.81% |
| Jun 30, 2021 | -583.12% |